The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
ENIGMA-Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes
Open accessAbstract
As genetic testing for predisposition to human diseases has become an increasingly common practice in medicine, the need for clear interpretation of the test results is apparent. However, for many disease genes, including the breast cancer susceptibility genes BRCA1 and BRCA2, a significant fraction of tests results in the detection of a genetic variant for which disease association is not known. The finding of an "unclassified" variant (UV)/variant of uncertain significance (VUS) complicates genetic test reporting and counseling. As these variants are individually rare, a large collaboration of researchers and clinicians will facilitate studies to assess their association with cancer predisposition. It was with this in mind that the ENIGMA consortium (www.enigmaconsortium.org) was initiated in 2009. The membership is both international and interdisciplinary, and currently includes more than 100 research scientists and clinicians from 19 countries. Within ENIGMA, there are presently six working groups focused on the following topics: analysis, clinical, database, functional, tumor histopathology, and mRNA splicing. ENIGMA provides a mechanism to pool resources, exchange methods and data, and coordinately develop and apply algorithms for classification of variants in BRCA1 and BRCA2. It is envisaged that the research and clinical application of models developed by ENIGMA will be relevant to the interpretation of sequence variants in other disease genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeted capture and massively parallel sequencing of 12 human exomes
Ng, S. B., Turner, E. H., Robertson, P. D., Flygare, S. D., Bigham, A. W., Lee, C., Shaffer, T., Wong, M., Bhattacharjee, A., Eichler, E. E., et al. (2009) · Nature · doi:10.1038/nature08250 · Cited by 2,030
Robson, M. E., Bradbury, A. R., Arun, B., Domchek, S. M., Ford, J. M., Hampel, H. L., Lipkin, S. M., Syngal, S., Wollins, D. S., & Lindor, N. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0996 · Cited by 934
Plon, S. E., Eccles, D. M., Easton, D., Foulkes, W. D., Genuardi, M., Greenblatt, M. S., Hogervorst, F. B. L., Hoogerbrugge, N., Spurdle, A. B., Tavtigian, S. V., et al. (2008) · Human Mutation · doi:10.1002/humu.20880 · Cited by 912
Self-citationWalsh, T., Lee, M. K., Casadei, S., Thornton, A. M., Stray, S. M., Pennil, C., Nord, A. S., Mandell, J. B., Swisher, E. M., & King, M.-C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007983107 · Cited by 487
Easton, D. F., Deffenbaugh, A. M., Pruss, D., Frye, C., Wenstrup, R. J., Allen-Brady, K., Tavtigian, S. V., Monteiro, A. N. A., Iversen, E. S., Couch, F. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/521032 · Cited by 455
Self-citationRobson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0660 · Cited by 421
Goldgar, D. E., Easton, D. F., Deffenbaugh, A. M., Monteiro, A. N. A., Tavtigian, S. V., & Couch, F. J. (2004) · The American Journal of Human Genetics · doi:10.1086/424388 · Cited by 391
Self-citationTavtigian, S. V., Byrnes, G. B., Goldgar, D. E., & Thomas, A. (2008) · Human Mutation · doi:10.1002/humu.20896 · Cited by 227
Self-citationRare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer
Tavtigian, S. V., Oefner, P. J., Babikyan, D., Hartmann, A., Healey, S., Le Calvez-Kelm, F., Lesueur, F., Byrnes, G. B., Chuang, S.-C., Forey, N., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.08.018 · Cited by 194
Self-citationGoldgar, D. E., Easton, D. F., Byrnes, G. B., Spurdle, A. B., Iversen, E. S., Greenblatt, M. S., & for the IARC Unclassified Genetic Variants Working Group (2008) · Human Mutation · doi:10.1002/humu.20897 · Cited by 188
Self-citationMassively parallel sequencing and rare disease
Ng, S. B., Nickerson, D. A., Bamshad, M. J., & Shendure, J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq390 · Cited by 178
Chenevix‐Trench, G., Healey, S. C., Lakhani, S. R., Waring, P., Cummings, M. C., Brinkworth, R. I., Deffenbaugh, A. M., Burbidge, L. A., Pruss, D., Judkins, T., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3546 · Cited by 150
Self-citationPrediction and assessment of splicing alterations: implications for clinical testing
Spurdle, A. B., Couch, F. J., Hogervorst, F. B. L., Radice, P., Sinilnikova, O. M., & for the IARC Unclassified Genetic Variants Working Group (2008) · Human Mutation · doi:10.1002/humu.20901 · Cited by 122
Self-citationFunctional Assays for Classification ofBRCA2Variants of Uncertain Significance
Farrugia, D. J., Agarwal, M. K., Pankratz, V. S., Deffenbaugh, A. M., Pruss, D., Frye, C., Wadum, L., Johnson, K., Mentlick, J., Tavtigian, S. V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-1587 · Cited by 116
Self-citationThe role of BRCA mutation testing in determining breast cancer therapy
Trainer, A. H., Lewis, C. R., Tucker, K., Meiser, B., Friedlander, M. L., & Ward, R. L. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.175 · Cited by 100
Schwartz, G. F., Hughes, K. S., Lynch, H. T., et al. (2008) · Cancer · doi:10.1002/cncr.23903 · Cited by 93
Clinically Applicable Models to CharacterizeBRCA1andBRCA2Variants of Uncertain Significance
Spearman, A. D., Sweet, K. M., Zhou, X.-P., McLennan, J., Couch, F. J., & Toland, A. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.8228 · Cited by 85
Self-citationSpurdle, A. B., Lakhani, S. R., Healey, S. C., Parry, S., Silva, L. M. D., Brinkworth, R. I., Hopper, J. L., Brown, M. A., Babikyan, D., Chenevix‐Trench, G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.2779 · Cited by 77
Self-citationGenotype to phenotype: Analyzing the effects of inherited mutations in colorectal cancer families
Heinen, C. D. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.09.004 · Cited by 76
Arnold, S., Buchanan, D. D., Barker, M. A., Jaskowski, L. A., Walsh, M. D., Birney, G., Woods, M. O., Hopper, J. L., Jenkins, M. A., Brown, M. A., et al. (2009) · Human Mutation · doi:10.1002/humu.20936 · Cited by 66
Self-citationIversen, E. S., Couch, F. J., Goldgar, D. E., Tavtigian, S. V., & Monteiro, Á. N. A. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-1214 · Cited by 62
Self-citationWalker, L. C., Whiley, P. J., Couch, F. J., Farrugia, D. J., Healey, S. C., Eccles, D., Lin, F., Butler, S., Goff, S., Thompson, B. A., et al. (2010) · Human Mutation · doi:10.1002/humu.21267 · Cited by 59
Self-citationWhiley, P. J., Guidugli, L., Walker, L. C., Healey, S. C., Thompson, B. A., Lakhani, S. R., Silva, L. M. D., kConFab Investigators, Tavtigian, S. V., Goldgar, D. E., et al. (2011) · Human Mutation · doi:10.1002/humu.21495 · Cited by 56
Self-citationGómez-García, E. B., Oosterwijk, J. C., Timmermans, M. M. M. S., van Asperen, C. J., Hogervorst, F. B. L., Hoogerbrugge, N., Oldenburg, R. A., Verhoef, S., Dommering, C. J., Ausems, M. G. E. M., et al. (2009) · Breast Cancer Research · doi:10.1186/bcr2223 · Cited by 52
Self-citationOsório, A., Milne, R. L., Honrado, E., Barroso, A., Dı́ez, O., Salazar, R., de la Hoya, M., Vega, A. I., & Benitez, J. J. (2007) · Human Mutation · doi:10.1002/humu.20470 · Cited by 40
Spurdle, A. B. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.03.009 · Cited by 37
Self-citationMurphy, J. A., Barrantes-Reynolds, R., Kocherlakota, R., Bond, J. P., & Greenblatt, M. S. (2004) · Human Mutation · doi:10.1002/humu.20083 · Cited by 31
Comprehensive prediction of mRNA splicing effects of BRCA1 and BRCA2 variants
Mucaki, E. J., Ainsworth, P., & Rogan, P. K. (2011) · Human Mutation · doi:10.1002/humu.21513 · Cited by 30
Cited by
Accurate classification of BRCA1 variants with saturation genome editing
Findlay, G. M., Daza, R. M., Martin, B., Zhang, M. D., Leith, A. P., Gasperini, M., Janizek, J. D., Huang, X., Starita, L. M., & Shendure, J. (2018) · Nature · doi:10.1038/s41586-018-0461-z · Cited by 843
Polak, P., Kim, J., Braunstein, L. Z., Karlic, R., Haradhavala, N. J., Tiao, G., Rosebrock, D., Livitz, D., Kübler, K., Mouw, K. W., et al. (2017) · Nature Genetics · doi:10.1038/ng.3934 · Cited by 531
Building the foundation for genomics in precision medicine
Aronson, S. J., & Rehm, H. L. (2015) · Nature · doi:10.1038/nature15816 · Cited by 492
Tumour lineage shapes BRCA-mediated phenotypes
Jonsson, P., Bandlamudi, C., Cheng, M. L., Srinivasan, P., Chavan, S. S., Friedman, N. D., Rosen, E. Y., Richards, A. L., Bouvier, N., Selcuklu, S. D., et al. (2019) · Nature · doi:10.1038/s41586-019-1382-1 · Cited by 401
Variant interpretation: functional assays to the rescue
Starita, L. M., Ahituv, N., Dunham, M. J., Kitzman, J. O., Roth, F. P., Seelig, G., Shendure, J., & Fowler, D. M. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.07.014 · Cited by 381
Metadata
- Authors
- Spurdle, A. B., Healey, S., Devereau, A., Hogervorst, F. B. L., Monteiro, A. N. A., Nathanson, K. L., Radice, P., Stoppa-Lyonnet, D., Tavtigian, S., Wappenschmidt, B., Couch, F. J., Goldgar, D. E., & ENIGMA, O. B. O.
- Venue
- Human Mutation
- Publisher
- Wiley
- Published
- 2011-11-03
- Volume
- 33
- Issue
- 1
- Pages
- 2-7
- ISSN
- 1059-7794 (ISSN-L)
- OpenAlex
- W2037117416
- Cited by
- 307
- References
- 28
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.